LGC reports half year trading in line with expectations
Update for the half year ended 30 September 2022
Read MoreTo contact the press office please email or call +44 7408 850 514
Update for the half year ended 30 September 2022
Read MoreLGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework
Read MoreAustralians identified by LGC's ongoing DNA work concerning remains discovered at Fromelles, northern France
Read MoreRoadmap to support the measurements associated with infectious disease and future pandemic readiness has recently been published
Read MoreFacility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies
Read MoreThis is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally.
Read MoreThe paper, titled “Monkeypox: another test for PCR”, focuses on how to ensure the PCR diagnosis tests being deployed for monkeypox will be most accurate and that lessons learned on PCR testing from the COVID-19 pandemic are applied to the current epidemic.
Read MoreThe exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.
Read MoreEasy-to-use app-based microlearning provides training in a range of cannabis-related topics
Read MoreExpands LGC’s offering to more than 180 allergen reference materials for a range of applications including method development and method verification
Read MoreUpdate
Read MoreAs we continue to celebrate Pride month, let’s take a look at several famous LGBTQ scientists throughout history that have changed and continue to change the world.
Read More